These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34306130)

  • 21. Prekallikrein deficiency in a 15-year-old boy with Ménière's disease: a case report.
    Criel M; Declau F; Schuermans C; Ver Elst K; Vermeiren S; Weekx S; Lemmens J
    Acta Clin Belg; 2017 Aug; 72(4):274-277. PubMed ID: 27615147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c.451dupT in KLKB1 is common in Nigerians, confirming a higher prevalence of severe prekallikrein deficiency in Africans compared to Europeans.
    Adenaeuer A; Ezigbo ED; Fawzy Nazir H; Barco S; Trinchero A; Laubert-Reh D; Strauch K; Wild PS; Lackner KJ; Lämmle B; Rossmann H
    J Thromb Haemost; 2021 Jan; 19(1):147-152. PubMed ID: 33073460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports.
    Girolami A; Rolland C; Sexton D; Vardi M; Bernstein JA
    Allergy Asthma Proc; 2020 Jan; 41(1):10-18. PubMed ID: 31888778
    [No Abstract]   [Full Text] [Related]  

  • 24. Prekallikrein (Fletcher factor) deficiency.
    Sollo DG; Saleem A
    Ann Clin Lab Sci; 1985; 15(4):279-85. PubMed ID: 3849948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction-a paradigmatic case report.
    Poli G; Castiglioni P; Montagnana M; Favaloro EJ; Lippi G
    Ann Transl Med; 2016 Nov; 4(21):426. PubMed ID: 27942517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe prekallikrein deficiency due to a compound heterozygosis in the KLKB1-gene].
    Maak B; Kochhan L; Heuchel P; Jenderny J
    Hamostaseologie; 2009 May; 29(2):187-9. PubMed ID: 19404525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged activated partial thromboplastin time with no clear explanation.
    Nakav S; Blickstein D; Raanani P; Rabizadeh E; Spectre G
    Blood Coagul Fibrinolysis; 2020 Apr; 31(3):225-228. PubMed ID: 31990752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prekallikrein deficiency in a dog.
    Chinn DR; Dodds WJ; Selcer BA
    J Am Vet Med Assoc; 1986 Jan; 188(1):69-71. PubMed ID: 3632973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr).
    Lombardi AM; Sartori MT; Cabrio L; Fadin M; Zanon E; Girolami A
    Thromb Haemost; 2003 Dec; 90(6):1040-5. PubMed ID: 14652634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hageman factor deficiency presentation and implications for management.
    Harper K; Friedland ML
    Conn Med; 1992 Sep; 56(9):469-71. PubMed ID: 1424610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A patient with a prolonged activated partial thromboplastin time and a deep intracerebral haemorrhage.
    Schindhelm RK; Wondergem MJ; Admiraal J; Nap G; Boekel ET; Hani L
    Case Rep Neurol; 2012 May; 4(2):131-6. PubMed ID: 22949911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prekallikrein deficiency in a dog.
    Okawa T; Yanase T; Shimokawa Miyama T; Hiraoka H; Baba K; Tani K; Okuda M; Mizuno T
    J Vet Med Sci; 2011 Jan; 73(1):107-11. PubMed ID: 20736516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence.
    Barco S; Sollfrank S; Trinchero A; Adenaeuer A; Abolghasemi H; Conti L; Häuser F; Kremer Hovinga JA; Lackner KJ; Loewecke F; Miloni E; Vazifeh Shiran N; Tomao L; Wuillemin WA; Zieger B; Lämmle B; Rossmann H
    J Thromb Haemost; 2020 Jul; 18(7):1598-1617. PubMed ID: 32202057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of sulfatides in factor-XII-dependent contact activation.
    Tans G; Griffin JH
    Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disorders in the contact phase system of blood coagulation as a cause of increased partial thromboplastin time].
    Siegert G; Plat M
    Z Gesamte Inn Med; 1988 May; 43(9):228-31. PubMed ID: 3407236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of contact activation by sulfatides.
    Tans G; Griffin JH
    Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acute lung injury as a consequence of fresh frozen plasma administration in a patient with factor XII deficiency].
    San Juan-Álvarez M; Sánchez-Zamora P; de la Flor-Robledo M
    Rev Esp Anestesiol Reanim; 2014 Oct; 61(8):446-50. PubMed ID: 24252352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged Activated Clotting Time Immediately Prior to Open Cardiac Surgery.
    Baker SM; Kiefer A; Carollo DS; Warrier RP
    Ochsner J; 2018; 18(4):423-424. PubMed ID: 30559632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation].
    Vogel G; Stürzebecher J; Klessen C; Lauten G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.